GOVX GeoVax Labs Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GOVX

Price (delayed)

$0.4405

Market cap

$11.76M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.89

Enterprise value

-$927,767

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On ...

Highlights
The EPS has soared by 70% year-on-year but it has declined by 20% since the previous quarter
GeoVax Labs's revenue has shrunk by 100% YoY
The company's gross profit has shrunk by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.geovax.com
Peers: ADXS ABBV

Key stats

What are the main financial stats of GOVX
Market
Shares outstanding
26.7M
Market cap
$11.76M
Enterprise value
-$927,767
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.28
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$23.76M
EBITDA
-$23.69M
Free cash flow
-$21.99M
Per share
EPS
-$0.89
Free cash flow per share
-$0.83
Book value per share
$0.34
Revenue per share
$0
TBVPS
$0.61
Balance sheet
Total assets
$16.2M
Total liabilities
$7.08M
Debt
$0
Equity
$9.12M
Working capital
$7.72M
Liquidity
Debt to equity
0
Current ratio
2.09
Quick ratio
1.79
Net debt/EBITDA
0.54
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-98.8%
Return on equity
-125.5%
Return on invested capital
N/A
Return on capital employed
-260.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GOVX stock price

How has the GeoVax Labs stock price performed over time
Intraday
-2.54%
1 week
-13.81%
1 month
-11.9%
1 year
-43.89%
YTD
-30.1%
QTD
-14.3%

Financial performance

How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.44M
Net income
-$23.76M
Gross margin
N/A
Net margin
N/A
GeoVax Labs's revenue has shrunk by 100% YoY
The company's gross profit has shrunk by 100% YoY
The operating income has contracted by 23% from the previous quarter and by 9% YoY
GeoVax Labs's net income has decreased by 23% from the previous quarter and by 6% YoY

Growth

What is GeoVax Labs's growth rate over time

Valuation

What is GeoVax Labs stock price valuation
P/E
N/A
P/B
1.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 70% year-on-year but it has declined by 20% since the previous quarter
The equity has dropped by 71% year-on-year and by 47% since the previous quarter
The P/B is 46% more than the last 4 quarters average of 0.9
GeoVax Labs's revenue has shrunk by 100% YoY

Efficiency

How efficient is GeoVax Labs business performance
The return on equity has dropped by 60% since the previous quarter and by 6% year-on-year
The ROA has dropped by 52% since the previous quarter and by 11% year-on-year

Dividends

What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOVX.

Financial health

How did GeoVax Labs financials performed over time
GOVX's total assets is 129% more than its total liabilities
The quick ratio has plunged by 75% YoY and by 59% from the previous quarter
GOVX's total liabilities has surged by 73% since the previous quarter and by 4.3% year-on-year
The debt is 100% smaller than the equity
The equity has dropped by 71% year-on-year and by 47% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.